178 related articles for article (PubMed ID: 28505316)
1. Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly-Onset Type 2 Diabetes.
Xin A; Mizukami H; Inaba W; Yoshida T; Takeuchi YK; Yagihashi S
J Clin Endocrinol Metab; 2017 Sep; 102(9):3162-3171. PubMed ID: 28505316
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of type 2 diabetes in Alzheimer disease.
Janson J; Laedtke T; Parisi JE; O'Brien P; Petersen RC; Butler PC
Diabetes; 2004 Feb; 53(2):474-81. PubMed ID: 14747300
[TBL] [Abstract][Full Text] [Related]
3. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.
Clark A; Wells CA; Buley ID; Cruickshank JK; Vanhegan RI; Matthews DR; Cooper GJ; Holman RR; Turner RC
Diabetes Res; 1988 Dec; 9(4):151-9. PubMed ID: 3073901
[TBL] [Abstract][Full Text] [Related]
4. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic pathology in non-insulin dependent diabetes (NIDDM).
Clark A; de Koning EJ; Hattersley AT; Hansen BC; Yajnik CS; Poulton J
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S39-47. PubMed ID: 8529518
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in islet amyloid deposition in the residual pancreas with new-onset diabetes secondary to pancreatic ductal adenocarcinoma.
Wang R; Liu Y; Liang Y; Zhou L; Chen MJ; Liu XB; Tan CL; Chen YH
World J Gastrointest Surg; 2023 Aug; 15(8):1703-1711. PubMed ID: 37701698
[TBL] [Abstract][Full Text] [Related]
7. Higher islet amyloid load in men than in women with type 2 diabetes mellitus.
Zhao HL; Sui Y; Guan J; He L; Lai FM; Zhong DR; Yang D; Baum L; Tong PC; Tomlinson B; Chan JC
Pancreas; 2008 Oct; 37(3):e68-73. PubMed ID: 18815541
[TBL] [Abstract][Full Text] [Related]
8. Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer.
Saruc M; Iki K; Pour PM
Histol Histopathol; 2010 Apr; 25(4):423-32. PubMed ID: 20183795
[TBL] [Abstract][Full Text] [Related]
9. Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients.
Kamata K; Mizukami H; Inaba W; Tsuboi K; Tateishi Y; Yoshida T; Yagihashi S
Amyloid; 2014 Sep; 21(3):191-201. PubMed ID: 25007035
[TBL] [Abstract][Full Text] [Related]
10. Islet Amyloid in Patients With Diabetes Due to Exocrine Pancreatic Disorders, Type 2 Diabetes, and Nondiabetic Patients.
Ueberberg S; Nauck MA; Uhl W; Montemurro C; Tannapfel A; Clark A; Meier JJ
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32271378
[TBL] [Abstract][Full Text] [Related]
11. Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.
Bruggeman BS; Campbell-Thompson M; Filipp SL; Gurka MJ; Atkinson MA; Schatz DA; Jacobsen LM
Front Endocrinol (Lausanne); 2021; 12():778912. PubMed ID: 34912300
[TBL] [Abstract][Full Text] [Related]
12. Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.
Clark A; Holman RR; Matthews DR; Hockaday TD; Turner RC
Diabetologia; 1984 Nov; 27(5):527-8. PubMed ID: 6391995
[TBL] [Abstract][Full Text] [Related]
13. Endocrine Pancreas in Cats With Diabetes Mellitus.
Zini E; Lunardi F; Zanetti R; Heller RS; Coppola LM; Ferro S; Guscetti F; Osto M; Lutz TA; Reusch CE; Cavicchioli L
Vet Pathol; 2016 Jan; 53(1):136-44. PubMed ID: 26113611
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and immunohistochemical analysis of the endocrine and exocrine pancreas in twelve cattle with insulin-dependent diabetes mellitus (IDDM).
Taniyama H; Hirayama K; Kagawa Y; Kurosawa T; Tajima M; Yoshino T; Furuoka H
J Vet Med Sci; 1999 Jul; 61(7):803-10. PubMed ID: 10458104
[TBL] [Abstract][Full Text] [Related]
15. Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide.
Ohsawa H; Kanatsuka A; Tokuyama Y; Yamaguchi T; Makino H; Yoshida S; Horie H; Mikata A; Kohen Y
Acta Endocrinol (Copenh); 1991 Jan; 124(1):45-53. PubMed ID: 2000701
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modification, inflammation and amyloid in the normal and diabetic cat pancreas.
Herndon AM; Breshears MA; McFarlane D
J Comp Pathol; 2014 Nov; 151(4):352-62. PubMed ID: 25124331
[TBL] [Abstract][Full Text] [Related]
17. Human IAPP amyloidogenic properties and pancreatic β-cell death.
Fernández MS
Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
[TBL] [Abstract][Full Text] [Related]
18. Islet Amyloid in Whole Pancreas Transplants for Type 1 Diabetes Mellitus (DM): Possible Role of Type 2 DM for Graft Failure.
León Fradejas M; Kandil D; Papadimitriou JC; del Pino Flórez Rial M; Prieto Sánchez E; Drachenberg CB
Am J Transplant; 2015 Sep; 15(9):2495-500. PubMed ID: 25926270
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in distribution of amyloid-positive islets in type-2 diabetic patients.
Borromeo CM; Pottier X; In't Veld PA; Pipeleers-Marichal MA; Kaufman L; Pipeleers DG; Van Schravendijk CF
Virchows Arch; 2005 Mar; 446(3):232-8. PubMed ID: 15791482
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for amyloid deposition in clinical pancreatic islet grafts.
Westermark GT; Davalli AM; Secchi A; Folli F; Kin T; Toso C; Shapiro AM; Korsgren O; Tufveson G; Andersson A; Westermark P
Transplantation; 2012 Jan; 93(2):219-23. PubMed ID: 22193043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
